GenSol Diagnostics
Biotechnology ResearchGeorgia, United States2-10 Employees
GenSol Diagnostics is a biotechnology research company located in Clayton, Georgia, that provides canine genetic testing to inform breeding practices and preventive wellness for dogs. The firm uses non-invasive sampling methods, including cheek swabs, and introduced nasal swabbing in 2026, with rapid 24–48 hour test results based on scientifically validated approaches. Its test catalog includes PRA-PRCD, CEA, VWD1, DM, EIC, and other genetic disorder panels, as well as coat and color locus tests such as Coat Length, E Locus, and D Locus. GenSol has pursued breed-specific customization, launching fully customizable panels in 2023 and breed-specific customizable panels in 2024, expanding its testing options over time. The company operates with a small team of 2–10 employees and maintains its website at gensoldx.com.